Recent findings indicate the oncofetal reprogramming in CRC allows the LGR5+ SC population to re-express fetal-like gene to sustain the hybrid state, potentially evade FOLFIRI treatment [87]. This evidence concerns the gene LGR5 and colorectal carcinoma.